ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HLA antibodies"

  • 2017 American Transplant Congress

    De Novo, Non-Donor Specific HLA Antibodies Are Associated with Inferior Allograft Outcomes After Kidney and Simultaneous Kidney-Pancreas Transplantation.

    S. Hassan,1 G. Lucisano,1 E. Santos,2 D. McKeown,3 D. Goodall,1 A. Gueret-Wardle,1 A. McLean,1 P. Brooks,2 M. Willicombe,1 D. Taube.1

    1Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom; 3Blood Transfusion, Imperial College Healthcare NHS Trust, London, United Kingdom

    Introduction: Donor specific antibodies [DSAs] occurring after transplantation are associated with poorer outcomes. However the significance of non-donor directed HLA antibodies [ndHLAs] after transplantation in…
  • 2017 American Transplant Congress

    Specific Gene Expression Signature of Complement-Activating Donor Specific Anti-HLA Antibody-Mediated Rejection in Kidney Allografts.

    C. Lefaucheur,1 D. Viglietti,1 L. Hidalgo,2 O. Aubert,1 A. Zeevi,3 P. Halloran,2 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2University of Alberta, Edmonton, Canada; 3University of Pittsburgh Medical Center, Pittsburgh

    Complement-binding anti-HLA DSA have demonstrated higher rejection rate and decreased allograft survival. However, their specific effects on rejection pathogenesis have not been identified. We investigated…
  • 2017 American Transplant Congress

    Presence of Complement Activating Donor Specific Antibodies Is Associated with Poor Renal Allograft Survival: Two Centre Retrospective Study.

    A. Babu,1,4,5 O. Shaw,2 L. Howe,2 N. Kessaris,3 A. Dorling,3 N. Mamode,3 R. Vaughan,2 N. Krishnan,5 R. Higgins,5 D. MItchell,1 D. Briggs,4 S. Daga.1,5,6

    1Warwick Medical School, University of Warwick, Coventry, United Kingdom; 2Clinical Transplantation Laboratories, Guy's Hospital, Viapath, London, United Kingdom; 3Nephrology and Transplantation, Guy's Hospital, London, United Kingdom; 4Histocompatibility and Immunogenetics, NHS Blood and Transfusion, Birmingham, United Kingdom; 5Nephrology and Transplantation, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom; 6Nephrology and Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Introduction: Complement fixing donor specific antibodies (DSA) as detected by presence of C3d at the time of rejection is associated with poor graft outcome;no studies…
  • 2017 American Transplant Congress

    Pre-Operative Desensitization for Live Donor Liver Transplantation with Strong Donor-Specific Antibodies.

    M. Fujiki,1 K. Hashimoto,1 A. Zhang,2 F. Aucejo,1 C. Quintini,1 T. Diago,1 B. Eghtesad,1 C. Miller.1

    1General Surgery, Cleveland Clinic, Cleveland, OH; 2Allogen Laboratories, Cleveland Clinic, Cleveland, OH

    Background: Presence of strong donor-specific antibodies (DSA) (MFI>4000) likely results in uncomplicated short-term outcome in whole liver transplants due to absorption of DSA by the…
  • 2017 American Transplant Congress

    Treating Refractory Liver Allograft Rejection with Photopheresis.

    I. Lopez Plaza,1 A. Eisenbrey,1 M. Raoufi,1 A. Yoshida,2 D. Moonka.2

    1Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, MI; 2Transplant Institute, Henry Ford Health System, Detroit, MI

    DSAs with persistent high titer alloantibodies are associated with refractory antibody mediated rejection (AMR) and liver injury.METHODS: We present 4 liver transplant (LT) patients refractory…
  • 2017 American Transplant Congress

    Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II.

    S. Montag,1,2 B. Ho,1 H. Bhagat,3 E. Lee,3,4 K. Atiemo,1 A. Daud,1 R. Kang,1 L. Zhao,1,2 J. Schwartz,3 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Dept of Preventive Medicine, Northwestern University, Chicago; 3Astellas Pharma Global Development, Northbrook; 4Now with UCB, Atlanta

    Patients with de novo donor-specific antibodies (dnDSA) show inferior graft survival in numerous small studies. We assessed the effect of dnDSA on graft and patient…
  • 2017 American Transplant Congress

    Pre-Transplant HLA-Specific B Cell Breadth of Reactivity in a Novel Multiplex Bead-Based Assay Predicts Rejection in Kidney Transplant Recipients.

    Z. Ilyas,1 A. Aki,1 A. Tambur,1 P. Heeger,2 M. Ansari.1

    1Northwestern University, Chicago; 2Icahn School of Medicine at Mount Sinai, New York

    Introduction: Recipients with broad sensitization to HLA defined by a high percentage of Panel Reactive Antibodies (PRA) are at higher immunologic risk for poor graft…
  • 2017 American Transplant Congress

    Outcomes of 100 ABO Incompatible Kidney Transplants: A Single US Center Experience.

    S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    IntroductionAcceptable patient and graft outcomes of ABO incompatible (ABOi) living donor kidney transplantation (LDKT) have been reported with the use of desensitization strategies. Data on…
  • 2017 American Transplant Congress

    Eliminating False Positive Virtual Crossmatch Results for Lung Transplant Candidates by Using Multiple Antibody Testing Platforms.

    O. Timofeeva,1 M. Kashem,2 S. Geier,1 D. Grogan,2 S. Keshavamurthy,2 J. Gomez-Abraham,2 Y. Toyoda,2 F. Cordova.2

    1Department of Pathology and Laboratory of Medicine, Temple University, Lewis Katz School of Medicine, Philadelphia, PA; 2Department of Cardiovascular Surgery, Temple University, Lewis Katz School of Medicine, Philadelphia, PA

    Purpose: At present, immunologic risk for lung transplant patients is evaluated based on Virtual crossmatch (VXM) by comparing recipient's HLA antibodies detected by Single antigen…
  • 2017 American Transplant Congress

    Timing of HLA Testing as a Means of Reducing Cost and Increasing Efficiency of Living Kidney Donation.

    E. Venniro, J. Taylor.

    Medicine, University of Rochester Medical Center, Rochester, NY

    Purpose: Creating an effective living kidney donor process can be a challenge for transplant centers. There needs to be a balance between efficiency, resources, patient…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 47
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences